OBJECTIVES/HYPOTHESIS: The primary objective of this study was to determine the safety profile of cochlear implantation (CI) in infants <12 months old. STUDY DESIGN: Retrospective review of institutional (Medical University of South Carolina [MUSC]) and national data (Pediatric American College of Surgeons-National Surgical Quality Improvement Program [ACS-NSQIP]). METHODS: Cases were subdivided into two groups according to age at CI: <12 months and 12 to 18 months. The primary outcome measure of interest was occurrence of a postoperative medical or surgical complication. Operative time, anesthesia time, time in the postoperative anesthesia care unit, and length of stay were also assessed. RESULTS: In infants <12 months of age, the incidence of a 30-day postoperative surgical complication using the ACS-NSQIP database was 3.6%; this did not differ from the rate observed in the 12- to 18-month-old group (3.2%, P = 1.0). In the MUSC series, the occurrence of a 30-day postoperative complication in children <12 months old was comparable (2.7%). At longer-term follow-up (mean = 3.7 years), the incidence of a postoperative surgical complication in infants <12 months old using MUSC data was 13.5%. When compared to older children at longer-term follow-up, no difference was noted (12.7%, P = 1.0). The incidence of a postoperative medical or anesthetic complication in children <12 months of age was extremely rare in both MUSC and ACS-NSQIP series (0% and 1.3%, respectively). CONCLUSIONS: Institutional and national data demonstrate that CI in children <12 months of age is a safe procedure. Although infants <12 months old are at risk for postoperative complications, the rates of surgical and medical complications were no different compared to children 12 to 18 months of age. LEVEL OF EVIDENCE: 4 Laryngoscope, 126:707-712, 2016.
OBJECTIVES/HYPOTHESIS: The primary objective of this study was to determine the safety profile of cochlear implantation (CI) in infants <12 months old. STUDY DESIGN: Retrospective review of institutional (Medical University of South Carolina [MUSC]) and national data (Pediatric American College of Surgeons-National Surgical Quality Improvement Program [ACS-NSQIP]). METHODS: Cases were subdivided into two groups according to age at CI: <12 months and 12 to 18 months. The primary outcome measure of interest was occurrence of a postoperative medical or surgical complication. Operative time, anesthesia time, time in the postoperative anesthesia care unit, and length of stay were also assessed. RESULTS: In infants <12 months of age, the incidence of a 30-day postoperative surgical complication using the ACS-NSQIP database was 3.6%; this did not differ from the rate observed in the 12- to 18-month-old group (3.2%, P = 1.0). In the MUSC series, the occurrence of a 30-day postoperative complication in children <12 months old was comparable (2.7%). At longer-term follow-up (mean = 3.7 years), the incidence of a postoperative surgical complication in infants <12 months old using MUSC data was 13.5%. When compared to older children at longer-term follow-up, no difference was noted (12.7%, P = 1.0). The incidence of a postoperative medical or anesthetic complication in children <12 months of age was extremely rare in both MUSC and ACS-NSQIP series (0% and 1.3%, respectively). CONCLUSIONS: Institutional and national data demonstrate that CI in children <12 months of age is a safe procedure. Although infants <12 months old are at risk for postoperative complications, the rates of surgical and medical complications were no different compared to children 12 to 18 months of age. LEVEL OF EVIDENCE: 4 Laryngoscope, 126:707-712, 2016.
Authors: Stephen Hoff; Maura Ryan; Denise Thomas; Elizabeth Tournis; Hannah Kenny; John Hajduk; Nancy M Young Journal: Otol Neurotol Date: 2019-04 Impact factor: 2.311
Authors: Patricia L Purcell; Nicholas L Deep; Susan B Waltzman; J Thomas Roland; Sharon L Cushing; Blake C Papsin; Karen A Gordon Journal: Trends Hear Date: 2021 Jan-Dec Impact factor: 3.293